Blood testing startup partners with Israel’s Sheba Medical Center to support COVID-19 quarantine measures -- MEDICA - World Forum for Medicine

18.03.2020

S.D Sight Diagnostics Ltd.

Blood testing startup partners with Israel’s Sheba Medical Center to support COVID-19 quarantine measures

Israeli blood testing startup Sight Diagnostics has announced a collaboration with Sheba Medical Center near Tel Aviv to mitigate the risk of contamination by COVID-19.

Sight’s OLO blood analyser will provide rapid complete blood count (CBC) results in a dedicated lab to process samples of COVID-19 patients who are being monitored and treated in a separate field hospital. 

Prior to deploying OLO for COVID-19 patient testing, Sight ran a two-month evaluation at the central lab of Sheba Medical Center, which led to the implementation for CBC testing.

Exhibitor Data Sheet